Predicting success of baclofen pump treatment in children with cerebral palsy
Part of Brain & nervous system clinical trials.
This study looks at children with cerebral palsy who are starting a treatment called intrathecal baclofen (ITB), which is a pump that delivers medicine to help with muscle stiffness. The goal is to find out what factors predict how well this treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 16 years old when starting this treatment.
- Your child must have a diagnosis of cerebral palsy (CP).
- This study is for children and teens in the Netherlands.
- You and your child must agree to take part in the study (give consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a special device can reliably measure muscle stiffness and spasticity (tight, overactive muscles) in children. It includes children with cerebral palsy and healthy children to compare measurements and improve accuracy.
This study tests whether a mild electrical stimulation applied to the skin over the spine can help children with cerebral palsy improve their movement and walking. Researchers will compare children who receive this treatment with children who don't have cerebral palsy to see if it makes a real difference.
This trial tests if combining spinal cord stimulation with a drug called 5-azacitidine can improve movement and muscle control in children with cerebral palsy. It aims to help with daily activities like walking or using hands.
This study tests if a pump that delivers baclofen directly into the spinal fluid can help children with cerebral palsy who have severe dystonia (uncontrolled muscle tightness). It looks at how well the treatment works and tracks progress over time.
This study looks at how well two surgeries help reduce muscle stiffness in children. It may help improve movement and comfort.
This trial tests if a treatment called ITB (intrathecal baclofen) can help reduce muscle stiffness in people with hereditary spastic paraplegia (HSP). Participants will receive the treatment and be followed over time to see how well it works.
Hear when a new Cerebral Palsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.